Piercing the Veil of Corporate Secrecy About Clinical Trials
The Hastings Center Report, Vol. 34, No. 5, pp. 14-18, 2004
5 Pages Posted: 11 Jun 2008
In the last decades, the pharmaceutical and biotechnology industry has burgeoned into one of the most profitable industries. With profit has come power. Backed by unprecedented financial means and pressured by stockholders' demand for investment returns, pharmaceutical companies have taken a much larger stake in all stages of medical research. Governmental policies and legislative initiatives such as the Bayh-Dole Act have also contributed to a shift in institutional approaches within academia to commercialization. In this paper, the author discusses the impact of these developments on the integrity of medical research.
Suggested Citation: Suggested Citation